Trials of Vertebroplasty for Vertebral Fractures

Authors:
  • WCWilliam Clark
    William Clark
  • SLStuart Lyon
    Stuart Lyon
  • JBJames Burnes
    James Burnes

Abstract
In the August 6 issue, Kallmes et al.1 report on the Investigational Vertebroplasty Safety and Efficacy Trial (ClinicalTrials.gov number, NCT00068822), and Buchbinder et al.2 report on a randomized trial of vertebroplasty for painful osteoporotic vertebral fractures (Australian New Zealand Clinical Trials Registry number, ACTRN012605000079640). We have serious concerns about both trials, which included patients with a duration of pain of up to 12 months. Vertebroplasty provides internal fixation of nonhealed osteoporotic vertebral fractures. It is well established that fixation of acute fractures elsewhere in the skeleton reduces fracture pain. Internal fixation of healed fractures is clearly inappropriate. Osteoporotic vertebral fractures usually heal within 8 weeks, although magnetic resonance imaging shows that edema persists longer. The study by Kallmes et al. involved outpatients exclusively, so that inpatients hospitalized with acute fracture pain were excluded. Furthermore, the protocol mandated 4 weeks of medical therapy before enrollment. This protocol effectively removed the entire population of patients with subacute fractures, resulting in a study on healed fractures. A more appropriate selection criterion would have been uncontrolled pain for less than 6 weeks.3 In the trial reported on by Buchbinder et al., the number of patients with pain for less than 6 weeks was far too small for a subgroup analysis.

This publication has 10 references indexed in Scilit: